pmcc logo sml



Here are the staff publications for August 2018.

Compiled by the Health Sciences Library (RMH, RWH, PMCC and Victorian Mental Health) 4th September 2018.


1. Arora SC, B.; Ahlawat, R. K.; Abaza, R.; Adshead, J.; Porter, J. R.; Challacombe, B.; Dasgupta, P.; Gandaglia, G.; Moon, D. A.; Yuvaraja, T. B.; Capitanio, U.; Larcher, A.; Porpiglia, F.; Mottrie, A.; Bhandari, M.; Rogers, C. Conversion of Robot-assisted Partial Nephrectomy to Radical Nephrectomy: A Prospective Multi-institutional Study. Urology 2018;113:85-90.

2. Baell JB, Leaver DJ, Hermans SJ, Kelly GL, Brennan MS, Downer NL, Nguyen N, Wichmann J, McRae HM, Yang Y, Cleary B, Lagiakos HR, Mieruszynski S, Pacini G, Vanyai HK, Bergamasco MI, May RE, Davey BK, Morgan KJ, Sealey AJ, Wang B, Zamudio N, Wilcox S, Garnham AL, Sheikh BN, Aubrey BJ, Doggett K, Chung MC, de Silva M, Bentley J, Pilling P, Hattarki M, Dolezal O, Dennis ML, Falk H, Ren B, Charman SA, White KL, Rautela J, Newbold A, Hawkins ED, Johnstone RW, Huntington ND, Peat TS, Heath JK, Strasser A, Parker MW, Smyth GK, Street IP, Monahan BJ, Voss AK, Thomas T. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. Nature 2018;560:253-7.

3. Beatty L, Kemp E, Butow P, Girgis A, Schofield P, Turner J, Hulbert-Williams NJ, Levesque JV, Koczwara B. A systematic review of psychotherapeutic interventions for women with metastatic breast cancer: Context matters. Psycho-Oncology 2018;27:34-42.

4. Behrenbruch CS, C.; Paquet-Fifield, S.; Molck, C.; Cho, H. J.; Michael, M.; Thomson, B. N. J.; Heriot, A. G.; Hollande, F. Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process. Clinical and Experimental Metastasis 2018;35:333-45.

5. Bell JAHF, V.; Mitchell, L.; Tam, S.; Wang, K.; Gupta, A. A.; Lewin, J. Perceptions of and decision making about clinical trials in adolescent and young adults with Cancer: a qualitative analysis. BMC Cancer 2018;18:629.

6. Biasi GP, M.; Guatelli, S.; Hardcastle, N.; Carolan, M.; Perevertaylo, V.; Kron, T.; Rosenfeld, A. B. A novel high-resolution 2D silicon array detector for small field dosimetry with FFF photon beams. Physica Medica 2018;45:117-26.

7. Blaschke SOC, C. C.; Schofield, P. Cancer Patients' Recommendations for Nature-Based Design and Engagement in Oncology Contexts: Qualitative Research. Herd 2018;11:45-55.

8. Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Toloczko A, Tiezzi DG, Taran FA, Sinn P, Sieh W, Sharma R, Rothstein JH, Ramon YCT, Paz-Ares L, Oszurek O, Orsulic S, Ness RB, Nelson G, Modugno F, Menkiszak J, McGuire V, McCauley BM, Mack M, Lubinski J, Longacre TA, Li Z, Lester J, Kennedy CJ, Kalli KR, Jung AY, Johnatty SE, Jimenez-Linan M, Jensen A, Intermaggio MP, Hung J, Herpel E, Hernandez BY, Hartkopf AD, Harnett PR, Ghatage P, Garcia-Bueno JM, Gao B, Fereday S, Eilber U, Edwards RP, de Sousa CB, de Andrade JM, Chudecka-Glaz A, Chenevix-Trench G, Cazorla A, Brucker SY, Australian Ovarian Cancer Study G, Alsop J, Whittemore AS, Steed H, Staebler A, Moysich KB, Menon U, Koziak JM, Kommoss S, Kjaer SK, Kelemen LE, Karlan BY, Huntsman DG, Hogdall E, Gronwald J, Goodman MT, Gilks B, Garcia MJ, Fasching PA, de Fazio A, Deen S, Chang-Claude J, Candido Dos Reis FJ, Campbell IG, Brenton JD, Bowtell DD, Benitez J, Pharoah PDP, Kobel M, Ramus SJ, Goode EL. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clinic Proceedings 2018;93:307-20.

9. Blyth BJC, A. J.; MacManus, M. P.; Martin, O. A. Radiation therapy-induced metastasis: radiobiology and clinical implications. Clinical and Experimental Metastasis 2018;35:223-36.

10. Boden I, Skinner EH, Browning L, Reeve J, Anderson L, Hill C, Robertson IK, Story D, Denehy L. Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial. BMJ 2018;360:j5916.

11. Brennan AJ, Law RHP, Conroy PJ, Noori T, Lukoyanova N, Saibil H, Yagita H, Ciccone A, Verschoor S, Whisstock JC, Trapani JA, Voskoboinik I. Perforin proteostasis is regulated through its C2 domain: supra-physiological cell death mediated by T431D-perforin. Cell Death and Differentiation 2018;25:1517-29.

12. Burbury KM, M. P. The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis. Clinical and Experimental Metastasis 2018;35:237-46.

13. Butler LA, Juneja S. Intrasinusoidal pattern of bone marrow infiltration by hepatosplenic T-cell lymphoma. Clinical Case Reports 2018;6:756-7.

14. Cabarkapa SP, M.; Sikaris, K.; O'Brien, J. S.; Bolton, D. M.; Lawrentschuk, N. Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer-time for a rethink? Prostate International 2018;6:1-6.

15. Chen QK, J.; Fu, C. The independence of and associations among apoptosis, autophagy, and necrosis. Signal Transduction and Targeted Therapy 2018;3:18.

16. Cherk MH, Kong G, Hicks RJ, Hofman MS. Changes in biodistribution on (68)Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression. Cancer Imaging 2018;18:3.

17. Chittleborough TJ, Luck A, Boussioutas A, Warrier S, Heriot AG. The conundrum of quality in colonoscopy. ANZ Journal of Surgery 2018;88:263-4.

18. Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, Hruban RH, Wolfgang CL, Goggins MG, Dal Molin M, Wang TL, Roden R, Klein AP, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Vogelstein JT, Browne JD, Schoen RE, Brand RE, Tie J, Gibbs P, Wong HL, Mansfield AS, Jen J, Hanash SM, Falconi M, Allen PJ, Zhou S, Bettegowda C, Diaz LA, Jr., Tomasetti C, Kinzler KW, Vogelstein B, Lennon AM, Papadopoulos N. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 2018;359:926-30.

19. Colombo M, Lopez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, Niederacher D, Schmidt AY, Varesco L, Wappenschmidt B, Bolla MK, Dennis J, Michailidou K, Wang Q, Aittomaki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadel A, Benitez J, Boeckx B, Bogdanova NV, Bojesen SE, Bonanni B, Brauch H, Brenner H, Burwinkel B, Chang-Claude J, Conroy DM, Couch FJ, Cox A, Cross SS, Czene K, Devilee P, Dork T, Eriksson M, Fasching PA, Figueroa J, Fletcher O, Flyger H, Gabrielson M, Garcia-Closas M, Giles GG, Gonzalez-Neira A, Guenel P, Haiman CA, Hall P, Hamann U, Hartman M, Hauke J, Hollestelle A, Hopper JL, Jakubowska A, Jung A, Kosma VM, Lambrechts D, Le Marchand L, Lindblom A, Lubinski J, Mannermaa A, Margolin S, Miao H, Milne RL, Neuhausen SL, Nevanlinna H, Olson JE, Peterlongo P, Peto J, Pylkas K, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, See MH, Southey MC, Swerdlow A, Teo SH, Toland AE, Tomlinson I, Truong T, van Asperen CJ, van den Ouweland AMW, van der Kolk LE, Winqvist R, Yannoukakos D, Zheng W, kConFab AI, Dunning AM, Easton DF, Henderson A, Hogervorst FBL, Izatt L, Offitt K, Side LE, van Rensburg EJ, Embrace S, Hebon S, McGuffog L, Antoniou AC, Chenevix-Trench G, Spurdle AB, Goldgar DE, Hoya M, Radice P. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Hum Mutation 2018;39:729-41.

20. Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT. The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics 2018;100:1100-18.

21. Corfield JMA, R.; Lawrentschuk, N. Health information quality on the internet for bladder cancer and urinary diversion: a multi-lingual analysis. Minerva Urologica e Nefrologica 2018;70:137-43.

22. Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, McCarthy S, Murnane A, Patchell S, Adams D. Clinical Oncology Society of Australia position statement on exercise in cancer care. Medical Journal of Australia 2018;209:184-7.

23. Cullinane C, Deacon GB, Drago PR, Erven AP, Junk PC, Luu J, Meyer G, Schmitz S, Ott I, Schur J, Webster LK, Klein A. Synthesis and antiproliferative activity of a series of new platinum and palladium diphosphane complexes. Dalton Transactions 2018;47:1918-32.

24. Curchin DJ, Harris VR, McCormack CJ, Smith SD. Changing trends in the incidence of invasive melanoma in Victoria, 1985-2015. Medical Journal of Australia 2018;208:265-9.

25. Curry EZ, C.; Masrour, N.; Patten, D. K.; Gallon, J.; Wilhelm-Benartzi, C. S.; Ghaem-Maghami, S.; Bowtell, D. D.; Brown, R. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis. Cancer Research 2018;78:1383-91.

26. Dall GV, Hawthorne S, Seyed-Razavi Y, Vieusseux J, Wu W, Gustafsson JA, Byrne D, Murphy L, Risbridger GP, Britt KL. Estrogen receptor subtypes dictate the proliferative nature of the mammary gland. Journal of Endocrinology 2018;237:323-36.

27. Daniel SG, Russ AD, Guthridge KM, Raina AI, Estes PS, Parsons LM, Richardson HE, Schroeder JA, Zarnescu DC. miR-9a mediates the role of Lethal giant larvae as an epithelial growth inhibitor in Drosophila. Biology Open 2018;7.

28. Darido CG, S. R.; Cullinane, C.; Partridge, D. D.; Walker, R.; Srivastava, S.; Roslan, S.; Carpinelli, M. R.; Dworkin, S.; Pearson, R. B.; Jane, S. M. Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin. Cell Death and Differentiation 2018;25:1146-59.

29. de Boer SMP, M. E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P. B.; Ledermann, J. A.; Khaw, P.; Colombo, A.; Fyles, A.; Baron, M. H.; Jurgenliemk-Schulz, I. M.; Kitchener, H. C.; Nijman, H. W.; Wilson, G.; Brooks, S.; Carinelli, S.; Provencher, D.; Hanzen, C.; Lutgens, Lchw; Smit, Vthbm; Singh, N.; Do, V.; D'Amico, R.; Nout, R. A.; Feeney, A.; Verhoeven-Adema, K. W.; Putter, H.; Creutzberg, C. L.; Portec study group. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncology 2018;19:295-309.

30. Desmedt CS, R.; Fornili, M.; Pruneri, G.; Van den Eynden, G.; Zoppoli, G.; Rothe, F.; Buisseret, L.; Garaud, S.; Willard-Gallo, K.; Brown, D.; Bareche, Y.; Rouas, G.; Galant, C.; Bertucci, F.; Loi, S.; Viale, G.; Di Leo, A.; Green, A. R.; Ellis, I. O.; Rakha, E. A.; Larsimont, D.; Biganzoli, E.; Sotiriou, C. Immune Infiltration in Invasive Lobular Breast Cancer. Journal of the National Cancer Institute 2018;110:768-76.

31. Dillon M, Flander L, Buchanan DD, Macrae FA, Emery JD, Winship IM, Boussioutas A, Giles GG, Hopper JL, Jenkins MA, Ait Ouakrim D. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios. PLoS Medicine 2018;15:e1002630.

32. Dubowitz JAS, E. K.; Riedel, B. J. Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis. Clinical and Experimental Metastasis 2018;35:347-58.

33. Dundas KP, E. M.; Batumalai, V.; Delaney, G. P.; Boxer, M. M.; Yap, M. L.; Ahern, V.; Chan, C.; David, S.; Dimigen, M.; Harvey, J. A.; Koh, E. S.; Lim, K.; Papadatos, G.; Lazarus, E.; Descellar, J.; Metcalfe, P.; Holloway, L. The impact of imaging modality (CT vs MRI) and patient position (supine vs prone) on tangential whole breast radiation therapy planning. Practical Radiation Oncology 2018;8:e87-e97.

34. Ebert MA, Hardcastle N, Kron T. Future forum, Hobart, October 29, 2017: examining the role of medical physics in cancer research. Australasian Physical and Engineering Sciences in Medicine 2018;41:571-9.

35. Farag MT, A.; Shankar, S.; Wong, L. M. Secondary spindle cell sarcoma following external beam radiotherapy for prostate cancer: a rare but devastating complication. BMJ Case Reports 2018;2018.

36. Fareh MJ, C. Probing RNA-Protein Interactions with Single-Molecule Pull-Down Assays. Methods in Molecular Biology 2018;1814:267-85.

37. Forcina VV, B.; Paulo, C.; Mitchell, L.; Bell, J. A.; Tam, S.; Wang, K.; Gupta, A. A.; Lewin, J. Perceptions and attitudes toward clinical trials in adolescent and young adults with cancer: a systematic review. Adolescent Health, Medicine and Therapeutics 2018;9:87-94.

38. Fox LCC, S. J.; Kausman, J. Y.; Shortt, J.; Hughes, P. D.; Wood, E. M.; Isbel, N. M.; de Malmanche, T.; Durkan, A.; Hissaria, P.; Blombery, P.; Barbour, T. D. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Internal Medicine Journal 2018;48:624-36.

39. Fox LCC, S. J.; Kausman, J. Y.; Shortt, J.; Hughes, P. D.; Wood, E. M.; Isbel, N. M.; de Malmanche, T.; Durkan, A.; Hissaria, P.; Blombery, P.; Barbour, T. D. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Nephrology (Carlton) 2018;23:507-17.

40. Gao Y, Weenink B, van den Bent MJ, Erdem-Eraslan L, Kros JM, Sillevis Smitt P, Hoang-Xuan K, Brandes AA, Vos M, Dhermain F, Enting R, Ryan GF, Chinot O, Ben Hassel M, van Linde ME, Mason WP, Gijtenbeek JMM, Balana C, von Deimling A, Gorlia T, Stupp R, Hegi ME, Baumert BG, French PJ. Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial. European Journal of Cancer 2018;94:168-78.

41. George JW, V.; Peifer, M.; Alexandrov, L. B.; Seidel, D.; Leenders, F.; Maas, L.; Muller, C.; Dahmen, I.; Delhomme, T. M.; Ardin, M.; Leblay, N.; Byrnes, G.; Sun, R.; De Reynies, A.; McLeer-Florin, A.; Bosco, G.; Malchers, F.; Menon, R.; Altmuller, J.; Becker, C.; Nurnberg, P.; Achter, V.; Lang, U.; Schneider, P. M.; Bogus, M.; Soloway, M. G.; Wilkerson, M. D.; Cun, Y.; McKay, J. D.; Moro-Sibilot, D.; Brambilla, C. G.; Lantuejoul, S.; Lemaitre, N.; Soltermann, A.; Weder, W.; Tischler, V.; Brustugun, O. T.; Lund-Iversen, M.; Helland, A.; Solberg, S.; Ansen, S.; Wright, G.; Solomon, B.; Roz, L.; Pastorino, U.; Petersen, I.; Clement, J. H.; Sanger, J.; Wolf, J.; Vingron, M.; Zander, T.; Perner, S.; Travis, W. D.; Haas, S. A.; Olivier, M.; Foll, M.; Buttner, R.; Hayes, D. N.; Brambilla, E.; Fernandez-Cuesta, L.; Thomas, R. K. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nature Communications 2018;9:1048.

42. Gherardin NAS, M. N.; Koay, H. F.; Mangas, K. M.; Seemann, T.; Stinear, T. P.; Eckle, S. B.; Berzins, S. P.; d'Udekem, Y.; Konstantinov, I. E.; Fairlie, D. P.; Ritchie, D. S.; Neeson, P. J.; Pellicci, D. G.; Uldrich, A. P.; McCluskey, J.; Godfrey, D. I. Human blood MAIT cell subsets defined using MR1 tetramers. Immunology and Cell Biology 2018;96:507-25.

43. Glassey R, Hardcastle SJ, O'Connor M, Ives A, kConFab I, Saunders C. Perceived influence of psychological consultation on psychological well-being, body image, and intimacy following bilateral prophylactic mastectomy: A qualitative analysis. Psycho-Oncology 2018;27:633-9.

44. Glassey R, O'Connor M, Ives A, Saunders C, Hardcastle SJ, kConFab I. Influences on decision-making for young women undergoing bilateral prophylactic mastectomy. Patient Education and Counseling 2018;101:318-23.

45. Gyorki DE. Management of In-Transit Melanoma: We Need Some High-Quality Data. Journal of Oncology Practice 2018;14:302-3.

46. Harris HRB, A.; Webb, P. M.; Nagle, C. M.; Jordan, S. J.; Risch, H. A.; Rossing, M. A.; Doherty, J. A.; Goodman, M. T.; Modugno, F.; Ness, R. B.; Moysich, K. B.; Kjaer, S. K.; Hogdall, E.; Jensen, A.; Schildkraut, J. M.; Berchuck, A.; Cramer, D. W.; Bandera, E. V.; Wentzensen, N.; Kotsopoulos, J.; Narod, S. A.; Phelan, C. M.; McLaughlin, J. R.; Anton-Culver, H.; Ziogas, A.; Pearce, C. L.; Wu, A. H.; Terry, K. L.; Ovarian Cancer Association, Consortium; Australian Ovarian Cancer Study, Group. Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers and Prevention 2018;27:174-82.

47. Heath JAC, M. A.; Thomas, A.; Solomon, B. Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma. Pediatric Blood & Cancer 2018;65:e27055.

48. Hegi F, D'Souza M, Azzi M, De Ruysscher D. Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy: A Systematic Review and Meta-Analysis. Clinical Lung Cancer 2018;19:199-212.

49. Hellig JCP, M.; Bolton, D.; Lawrentschuk, N.; Carpinteri, S.; Sampurno, S.; Malaterre, J.; Millen, R.; Dean, M.; Kong, J.; Chittleborough, T.; Heriot, A.; Lynch, A.C.; Ramsay, R.G. Experimental study of delivery of humidified-warm carbon dioxide during open abdominal surgery. World Journal of Urology 2018;105:597-605.

50. Hendry S, Cooper WA, Fox SB. Response to Editorial: The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back? Journal of Thoracic Oncology 2018;13:e185-e6.

51. Hennessey DBW, G.; Moon, D.; Kinnear, N.; Bolton, D. M.; Lawrentschuk, N.; Chan, Y. K. Strategies for success: a multi-institutional study on robot-assisted partial nephrectomy for complex renal lesions. BJU International 2018;121 Suppl 3:40-7.

52. Hiddemann W, Barbui AM, Canales MA, Cannell PK, Collins GP, Durig J, Forstpointner R, Herold M, Hertzberg M, Klanova M, Radford J, Seymour JF, Tobinai K, Trotman J, Burciu A, Fingerle-Rowson G, Wolbers M, Nielsen T, Marcus RE. Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety. Journal of Clinical Oncology 2018;36:2395-404.

53. House IG, Petley EV, Beavis PA. Tumor-derived exosomes modulate T cell function through transfer of RNA. FEBS Journal 2018;285:1030-2.

54. Hu J, Merriner DJ, O'Connor AE, Houston BJ, Furic L, Hedger MP, O'Bryan MK. Epididymal cysteine-rich secretory proteins are required for epididymal sperm maturation and optimal sperm function. Molecular Human Reproduction 2018;24:111-22.

55. Huo CW, Hill P, Chew G, Neeson PJ, Halse H, Williams ED, Henderson MA, Thompson EW, Britt KL. High mammographic density in women is associated with protumor inflammation. Breast Cancer Research 2018;20:92.

56. Ilic DE, S. M.; Allan, C. A.; Jung, J. H.; Murphy, D.; Frydenberg, M. Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review. BJU International 2018;121:845-53.

57. Jain P, Nogueras Gonzalez GM, Kanagal-Shamanna R, Rozovski U, Sarwari N, Tam C, Wierda WG, Thompson PA, Jain N, Luthra R, Quesada A, Sanchez-Petitto G, Ferrajoli A, Burger J, Kantarjian H, Cortes J, O'Brien S, Keating MJ, Estrov Z. The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. British Journal of Haematology 2018;180:33-40.

58. Jenkins MP, M.; Walker, J. G.; D. Emery J; Macrae, F.; Qama, A.; Boussioutas, A. 'Why don't I need a colonoscopy?' A novel approach to communicating risks and benefits of colorectal cancer screening. Australian Journal of General Practice 2018;47:343-9.

59. Jose V, Fumagalli D, Rothe F, Majjaj S, Loi S, Michiels S, Sotiriou C. Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays. PloS One 2018;13:e0203346.

60. Juresic E, Liney GP, Rai R, Descalar J, Lee M, Wong K, Moses D, Veera J, Holloway L. An assessment of set up position for MRI scanning for the purposes of rectal cancer radiotherapy treatment planning. Journal of Medical Radiation Sciences 2018;65:22-30.

61. Karapetis CSS, B.; Koczwara, B.; Harrup, R.; Milleshkin, L.; Parente, P.; Millward, M.; Haines, I.; Blinman, P.; Olver, I. Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying. Internal Medicine Journal 2018;48:774-9.

62. Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Australian Ovarian Cancer Study G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, Chang-Claude J, Behrens S, Moysich KB, Cannioto R, Lele S, Odunsi K, Goodman MT, Shvetsov YB, Thompson PJ, Wilkens LR, Dork T, Antonenkova N, Bogdanova N, Hillemanns P, Runnebaum IB, du Bois A, Harter P, Heitz F, Schwaab I, Butzow R, Pelttari LM, Nevanlinna H, Modugno F, Edwards RP, Kelley JL, Ness RB, Karlan BY, Lester J, Orsulic S, Walsh C, Kjaer SK, Jensen A, Cunningham JM, Vierkant RA, Giles GG, Bruinsma F, Southey MC, Hildebrandt MAT, Liang D, Lu K, Wu X, Sellers TA, Levine DA, Schildkraut JM, Iversen ES, Terry KL, Cramer DW, Tworoger SS, Poole EM, Bandera EV, Olson SH, Orlow I, Vestrheim Thomsen LC, Bjorge L, Krakstad C, Tangen IL, Kiemeney LA, Aben KKH, Massuger L, van Altena AM, Pejovic T, Bean Y, Kellar M, Cook LS, Le ND, Brooks-Wilson A, Gronwald J, Cybulski C, Jakubowska A, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Hogdall E, Engelholm SA, Hogdall C, Lundvall L, Nedergaard L, Pharoah PDP, Dicks E, Song H, Tyrer JP, McNeish I, Siddiqui N, Carty K, Glasspool R, Paul J, Campbell IG, Eccles D, Whittemore AS, McGuire V, Rothstein JH, Sieh W, Narod SA, Phelan CM, McLaughlin JR, Risch HA, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Gentry-Maharaj A, Ramus SJ, Wu AH, Pearce CL, Lee AW, Pike MC, Kupryjanczyk J, Podgorska A, Plisiecka-Halasa J, Sawicki W, Goode EL, Berchuck A, Ovarian Cancer Association C. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences 2018;19.

63. Kothari GL, A.; Tree, A. C.; van As, N. J.; Moghanaki, D.; Lo, S. S.; Ost, P.; Siva, S. Stereotactic Body Radiotherapy for Primary Prostate Cancer. Technology in Cancer Research & Treatment 2018;17:1533033818789633.

64. Lai-Kwon J, Siva S, Lewin J. Assessing the Clinical Utility of Computed Tomography-Based Radiomics. Oncologist 2018;23:747-9.

65. Lamb BW, Alghazo O, Murphy DG. Balancing the benefits and harms of radiotherapy post-radical prostatectomy. Translational Andrology and Urology 2018;7:S128-S31.

66. Lasocki AG, F.; Tacey, M.; Drummond, K.; Stuckey, S. Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival. Journal of Clinical Neuroscience 2018;47:168-73.

67. Lawrence NJ, Chan H, Toner G, Stockler MR, Martin A, Yip S, Wong N, Yeung A, Mazhar D, Pashankar F, Frazier L, McDermott R, Walker R, Tan H, Davis ID, Grimison P, Anzup. Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours. BMC Cancer 2018;18:854.

68. Lawrentschuk N. Editorial Comment. Journal of Urology 2018;200:359.

69. Lawrentschuk N. Time to link compensation to best practice? BJU International 2018;121 Suppl 3:5.

70. Lee B, Tran B, Hsu AL, Taylor GR, Fox SB, Fellowes A, Marquis R, Mooi J, Desai J, Doig K, Ekert P, Gaff C, Herath D, Hamilton A, James P, Roberts A, Snyder R, Waring P, McArthur G. Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting. Internal Medicine Journal 2018;48:786-94.

71. Lee MM, MacKinlay A, Semira C, Schieber C, Jimeno Yepes AJ, Lee B, Wong R, Hettiarachchige CKH, Gunn N, Tie J, Wong HL, Skinner I, Jones IT, Keck J, Kosmider S, Tran B, Field K, Gibbs P. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival. Clinical Colorectal Cancer 2018;17:e569-e77.

72. Lewin J, Davidson S, Anderson ND, Lau BY, Kelly J, Tabori U, Salah S, Butler MO, Aung KL, Shlien A, Dickson BC, Abdul Razak AR. Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft Part Sarcoma. Cancer Immunology Research 2018.

73. Lewin JS, L.; Kee, D.; Walpole, I.; Sanelli, A.; Te Marvelde, L.; Herschtal, A.; Spillane, J.; Gyorki, D.; Speakman, D.; Estall, V.; Donahoe, S.; Pohl, M.; Pope, K.; Chua, M.; Sandhu, S.; McArthur, G. A.; McCormack, C. J.; Henderson, M.; Hicks, R. J.; Shackleton, M. Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma. Annals of Oncology 2018;29:1569-74.

74. Leyden JP, N.; Chan, D.; Michael, M.; Clarke, S.; Khasraw, M.; Price, T. Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global survey. Asia Pacific Journal of Clinical Oncology 2018;14:256-63.

75. Lim A, Allen M, Lee S, Riedel B. Transcutaneous carbon dioxide monitoring during procedures requiring sedation and future implications for patients at risk of respiratory depression. Canadian Journal of Anaesthesia 2018;65:1078-9.

76. Lindeman NIC, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; Kwiatkowski, D. J.; Ladanyi, M.; Nowak, J. A.; Sholl, L.; Temple-Smolkin, R.; Solomon, B.; Souter, L. H.; Thunnissen, E.; Tsao, M. S.; Ventura, C. B.; Wynes, M. W.; Yatabe, Y. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Journal of Molecular Diagnostics 2018;20:129-59.

77. Lindeman NIC, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; Kwiatkowski, D. J.; Ladanyi, M.; Nowak, J. A.; Sholl, L.; Temple-Smolkin, R.; Solomon, B.; Souter, L. H.; Thunnissen, E.; Tsao, M. S.; Ventura, C. B.; Wynes, M. W.; Yatabe, Y. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Journal of Thoracic Oncology 2018;13:323-58.

78. Lindeman NIC, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; Kwiatkowski, D. J.; Ladanyi, M.; Nowak, J. A.; Sholl, L.; Temple-Smolkin, R.; Solomon, B.; Souter, L. H.; Thunnissen, E.; Tsao, M. S.; Ventura, C. B.; Wynes, M. W.; Yatabe, Y. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Archives of Pathology and Laboratory Medicine 2018;142:321-46.

79. Luen SW, S. W.; Mar, V.; Kelly, J. W.; McLean, C.; McArthur, G. A.; Haydon, A. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics. American Journal of Clinical Oncology 2018;41:90-4.

80. Malpas CB, Saling MM, Velakoulis D, Desmond P, Hicks RJ, Zetterberg H, Blennow K, O'Brien TJ. Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type. Journal of Alzheimer's Disease 2018;62:417-27.

81. Martin OAA, R. L. Editorial: Therapy-induced metastasis. Clinical and Experimental Metastasis 2018;35:219-21.

82. Maurer MJ, Habermann TM, Shi Q, Schmitz N, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Flowers CR, Coiffier B. Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials. Annals of Oncology 2018;29:1822-7.

83. Mohr PA, P.; Arance, A.; McArthur, G.; Hernaez, A.; Kaskel, P.; Shinde, R.; Stevinson, K. Real-world treatment patterns and outcomes among metastatic cutaneous melanoma patients treated with ipilimumab. Journal of the European Academy of Dermatology and Venereology 2018;32:962-71.

84. Monterosso LT, K.; Platt, V.; Lobb, E.; Musiello, T.; Bulsara, C.; Stratton, K.; Joske, D.; Krishnasamy, M. Living With Multiple Myeloma: A Focus Group Study of Unmet Needs and Preferences for Survivorship Care. Journal of Patient Experience 2018;5:6-15.

85. Morgan DDM, C.; Garner, J.; Currow, D. C. Subacute Rehabilitation Does Have Benefits for Patients With Advanced Cancer. Journal of Pain and Symptom Management 2018;55:e1-e2.

86. Mui MA, T.; Warrier, S. K.; Lynch, A. C.; Heriot, A. G. Detection of incidental colorectal pathology on positron emission tomography/computed tomography. ANZ Journal of Surgery 2018;88:E122-E6.

87. Muscat AMW, N. C.; Drummond, K. J.; Algar, E. M.; Khasraw, M.; Verhaak, R.; Field, K.; Rosenthal, M. A.; Ashley, D. M. The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection. Oncotarget 2018;9:7844-58.

88. Musiienko AMA, S.; Simpson, J. A. D.; Warrier, S.; Lynch, A. C.; Heriot, A. G. Preoperative chemoradiation for an ascending colon tumour: novel approach to achieve a complete resection. ANZ Journal of Surgery 2018;88:E342-E4.

89. Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T. Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics 2018;100:652-69.

90. Nishio MK, D. W.; Wu, Y. L.; Nakagawa, K.; Solomon, B. J.; Shaw, A. T.; Hashigaki, S.; Ohki, E.; Usari, T.; Paolini, J.; Polli, A.; Wilner, K. D.; Mok, T. Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment 2018;50:691-700.

91. Nunez Villacis L, Wong MS, Ferguson LL, Hein N, George AJ, Hannan KM. New Roles for the Nucleolus in Health and Disease. Bioessays 2018;40:e1700233.

92. Nzenza T, Murphy DG. PRECISION delivers on the PROMIS of mpMRI in early detection. Nature Reviews Urology 2018;15:529-30.

93. O'Donnell T, Christie EL, Ahuja A, Buros J, Aksoy BA, Bowtell DDL, Snyder A, Hammerbacher J. Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer. BMC Cancer 2018;18:87.

94. Oliver AJ, Lau PKH, Unsworth AS, Loi S, Darcy PK, Kershaw MH, Slaney CY. Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses. Frontiers in Immunology 2018;9:70.

95. Papa NP, MacInnis RJ, English DR, Bolton D, Davis ID, Lawrentschuk N, Millar JL, Severi G, Hopper JL, Giles GG. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study. Cancer Causes and Control 2018;29:93-102.

96. Pascoe C, Christidis D, Clouston D, Lawrentschuk N. Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: first reported case of yet another mask. BMJ Case Reports 2018;2018.

97. Patchett AL, Wilson R, Charlesworth JC, Corcoran LM, Papenfuss AT, Lyons BA, Woods GM, Tovar C. Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells. Oncotarget 2018;9:15895-914.

98. Pearson HBL, J.; Meniel, V. S.; Fennell, C. M.; Waring, P.; Montgomery, K. G.; Rebello, R. J.; Macpherson, A. A.; Koushyar, S.; Furic, L.; Cullinane, C.; Clarkson, R. W.; Smalley, M. J.; Simpson, K. J.; Phesse, T. J.; Shepherd, P. R.; Humbert, P. O.; Sansom, O. J.; Phillips, W. A. Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth. Cancer Discovery 2018;8:764-79.

99. Perera M, Papa N, Ischia J, Christidis D, Bolton D, Lawrentschuk N. Trends in percutaneous renal biopsy: The evolving diagnostic pathway for the small renal mass. Urology Annals 2018;10:237-9.

100. Perera ML, Gnaneswaran N, Roberts MJ, Lawrentschuk N, Ritchie P, Chan STF. Increased burden on metropolitan urological services: The era of the Australian National Emergency Access Targets (NEAT or the "4-h target"). Urology Annals 2018;10:146-9.

101. Petelin LL, D.; Mitchell, G.; James, P. A.; Trainer, A. H. Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments. Value in Health 2018;21:891-3.

102. Poon CLCB, A. M.; Richardson, H. E. Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue. International Journal of Molecular Sciences 2018;19.

103. Porter LH, Hashimoto K, Lawrence MG, Pezaro C, Clouston D, Wang H, Papargiris M, Thorne H, Li J, kConFab, Ryan A, Norden S, Moon D, Bolton DM, Sengupta S, Frydenberg M, Murphy DG, Risbridger GP, Taylor RA. Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells. BJU International 2018;121:971-8.

104. Poulsen MM, D.; Veness, M.; Estall, V.; Hruby, G.; Kumar, M.; Pullar, A.; Tripcony, L.; Rischin, D. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03. Journal of Medical Imaging and Radiation Oncology 2018;62:412-9.

105. Rasmussen V, Forrest LE, Rogasik M, Girodet M, Meeus P, Sunyach MP, Blay JY, Bally O, Brahmi M, Ballinger ML, Niedermayr E, Thomas DM, Halliday J, James P, Ray-Coquard I, Young MA, International Sarcoma Kindred S. A comparison of Australian and French families affected by sarcoma: perceptions of genetics and incidental findings. Personalized Medicine 2018;15:13-24.

106. Rebello RJH, A. V.; Furic, L. PIM activity in tumours: A key node of therapy resistance. Adv Biol Regul 2018;67:163-9.

107. Rees MJL, H.; Spillane, J.; Speakman, D.; McCormack, C.; Donahoe, S.; Pohl, M.; Webb, A.; Gyorki, D.; Henderson, M. A. Melanoma in the very elderly, management in patients 85years of age and over. Journal of Geriatric Oncology 2018;9:488-93.

108. Reynolds HM, Parameswaran BK, Finnegan ME, Roettger D, Lau E, Kron T, Shaw M, Chander S, Siva S. Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma. PloS One 2018;13:e0202387.

109. Ross DM, Burbury KL, Grigg AP, Hughes TP, Seymour JF. Management of Pregnancy in Women With Chronic Myeloid Leukemia. Journal of Clinical Oncology 2018;36:2657-8.

110. Roviello GC, S. P.; Multari, A. G.; Paganini, G.; Chiriaco, G.; Conca, R.; Petrioli, R.; Generali, D.; Rosellini, P.; Aieta, M. Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer. Oncotarget 2018;9:22332-9.

111. Russell L, Ugalde A, Milne D, Austin D, Livingston PM. Digital Characteristics and Dissemination Indicators to Optimize Delivery of Internet-Supported Mindfulness-Based Interventions for People With a Chronic Condition: Systematic Review. JMIR Mental Health 2018;5:e53.

112. Sanchez-Vega FM, M.; Armenia, J.; Chatila, W. K.; Luna, A.; La, K. C.; Dimitriadoy, S.; Liu, D. L.; Kantheti, H. S.; Saghafinia, S.; Chakravarty, D.; Daian, F.; Gao, Q.; Bailey, M. H.; Liang, W. W.; Foltz, S. M.; Shmulevich, I.; Ding, L.; Heins, Z.; Ochoa, A.; Gross, B.; Gao, J.; Zhang, H.; Kundra, R.; Kandoth, C.; Bahceci, I.; Dervishi, L.; Dogrusoz, U.; Zhou, W.; Shen, H.; Laird, P. W.; Way, G. P.; Greene, C. S.; Liang, H.; Xiao, Y.; Wang, C.; Iavarone, A.; Berger, A. H.; Bivona, T. G.; Lazar, A. J.; Hammer, G. D.; Giordano, T.; Kwong, L. N.; McArthur, G.; Huang, C.; Tward, A. D.; Frederick, M. J.; McCormick, F.; Meyerson, M.; Cancer Genome Atlas Research, Network; Van Allen, E. M.; Cherniack, A. D.; Ciriello, G.; Sander, C.; Schultz, N. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 2018;173:321-37.e10.

113. Savas PV, B.; Ye, C.; Salim, A.; Mintoff, C. P.; Caramia, F.; Salgado, R.; Byrne, D. J.; Teo, Z. L.; Dushyanthen, S.; Byrne, A.; Wein, L.; Luen, S. J.; Poliness, C.; Nightingale, S. S.; Skandarajah, A. S.; Gyorki, D. E.; Thornton, C. M.; Beavis, P. A.; Fox, S. B.; Kathleen Cuningham Foundation Consortium for Research into Familial Breast, Cancer; Darcy, P. K.; Speed, T. P.; Mackay, L. K.; Neeson, P. J.; Loi, S. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nature Medicine 2018;24:986-93.

114. Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM, Jr., Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordstrom T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Hakansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gomez-Caamano A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castano-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Roder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Dominguez MG, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Profile S, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Australian Prostate Cancer B, Study I, Canary PI, Breast, Prostate Cancer Cohort C, Consortium P, Cancer of the Prostate in S, Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility L, Genetic A, Mechanisms in Oncology /Elucidating Loci Involved in Prostate Cancer Susceptibility C, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics 2018;50:928-36.

115. Senan S, Rusthoven CG, Slotman BJ, Siva S. Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017. Journal of Thoracic Oncology 2018;13:488-96.

116. Seymour JF, Kipps TJ, Eichhorst B, Hillmen P, D'Rozario J, Assouline S, Owen C, Gerecitano J, Robak T, De la Serna J, Jaeger U, Cartron G, Montillo M, Humerickhouse R, Punnoose EA, Li Y, Boyer M, Humphrey K, Mobasher M, Kater AP. Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia. New England Journal of Medicine 2018;378:1107-20.

117. Seymour JF, Mobasher M, Kater AP. Venetoclax-Rituximab in Chronic Lymphocytic Leukemia. New England Journal of Medicine 2018;378:2143-4.

118. Shi Q, Schmitz N, Ou FS, Dixon JG, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Habermann TM, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Coiffier B, Flowers CR. Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL). Journal of Clinical Oncology 2018;36:2593-602.

119. Sim SA, Leung VKY, Ritchie D, Slavin MA, Sullivan SG, Teh BW. Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing. Biology of Blood and Marrow Transplantation 2018;24:1490-6.

120. Siow ZR, De Boer RH, Lindeman GJ, Mann GB. Spotlight on the utility of the Oncotype DX((R)) breast cancer assay. International Journal of Women's Health 2018;10:89-100.

121. Siva S, Louie AV, Warner A, Muacevic A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh B, Correa RJ, Lo SS, Staehler M. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Cancer 2018;124:934-42.

122. Skaczkowski G, White V, Thompson K, Bibby H, Coory M, Pinkerton R, Nicholls W, Orme LM, Conyers R, Phillips MB, Osborn M, Harrup R, Anazodo A. Factors influencing the documentation of fertility-related discussions for adolescents and young adults with cancer. European Journal of Oncology Nursing 2018;34:42-8.

123. Smallwood N, Barnes H, McDonald J, Manser R. Author reply. Internal Medicine Journal 2018;48:486-7.

124. Smith K, Winstanley J, Boyle F, O'Reilly A, White M, Antill YC. Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy. Supportive Care in Cancer 2018;26:483-9.

125. Snow HR, B.; Gyorki, D.; Henderson, M. A.; Speakman, D. Restricted venous access after lymph node dissection: no evidence (voodoo). ANZ Journal of Surgery 2018;88:131-2.

126. Sobhani N, Roviello G, Corona SP, Scaltriti M, Ianza A, Bortul M, Zanconati F, Generali D. The prognostic value of PI3K mutational status in breast cancer: A meta-analysis. Journal of Cellular Biochemistry 2018;119:4287-92.

127. Soo RA, Yun Lim JS, Asuncion BR, Fazreen Z, Herrera MC, Mohd Omar MF, Diem Phuong NH, Seet JE, Amanuel B, Iacopetta B, Byrne D, Hendry S, Fox S, Soong R. Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples. Oncotarget 2018;9:6841-51.

128. Soukup T, Lamb BW, Arora S, Darzi A, Sevdalis N, Green JS. Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature. Journal of Multidisciplinary Healthcare 2018;11:49-61.

129. Spruyt O. The Status of Palliative Care in the Asia-Pacific Region. Asia Pacific Journal of Oncology Nursing 2018;5:12-4.

130. Taieb DH, R. J.; Pacak, K. New Challenges in Nuclear Endocrinology. Journal of Nuclear Medicine 2018;59:573-4.

131. Thursky K, Lingaratnam S, Jayarajan J, Haeusler GM, Teh B, Tew M, Venn G, Hiong A, Brown C, Leung V, Worth LJ, Dalziel K, Slavin MA. Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs. BMJ Open Quality 2018;7:e000355.

132. Trubiano JAS, K.; Redwood, A. J.; Pavlos, R.; Konvinse, K. C.; Aung, A. K.; Slavin, M. A.; Thursky, K. A.; Grayson, M. L.; Phillips, E. J. The Combined Utility of Ex Vivo IFN-gamma Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions. Journal of Allergy and Clinical Immunology: In Practice 2018;6:1287-96 e1.

133. Valpione SC, M. S.; Mangana, J.; Mooradian, M. J.; McArthur, G.; Schadendorf, D.; Hauschild, A.; Menzies, A. M.; Arance, A.; Ascierto, P. A.; Di Giacomo, A.; de Rosa, F.; Larkin, J.; Park, J. J.; Goldinger, S. M.; Sullivan, R. J.; Xu, W.; Livingstone, E.; Weichenthal, M.; Rai, R.; Gaba, L.; Long, G. V.; Lorigan, P. Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. European Journal of Cancer 2018;91:116-24.

134. Van Audenaerde JRM, Roeyen G, Darcy PK, Kershaw MH, Peeters M, Smits ELJ. Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review. Pharmacology and Therapeutics 2018;189:31-44.

135. Vodanovich DA, PF MC. Soft-tissue Sarcomas. Indian Journal of Orthopaedics 2018;52:35-44.

136. Vu TMS, J. A.; Lynch, A. C.; Warrier, S.; Heriot, A. Appendiceal adenocarcinoma masquerading as a primary rectal tumour. ANZ Journal of Surgery 2018;88:E556-E7.

137. Vu TMS, J. A.; Alzarhani, S.; Lynch, A. C.; Warrier, S.; Heriot, A. Rectal adenocarcinoma perforation following palliative colorectal stenting. ANZ Journal of Surgery 2018;88:E558-E9.

138. Wiede FT, T. Isolation and Characterization of Mouse Intrahepatic Lymphocytes by Flow Cytometry. Methods in Molecular Biology 2018;1725:301-11.

139. Wiley G, Piper A, Phyllis Butow AM, Schofield P, Douglas F, Roy J, Nolte L, Jefford M. Developing Written Information for Cancer Survivors from Culturally and Linguistically Diverse Backgrounds: Lessons Learnt. Asia Pacific Journal of Oncology Nursing 2018;5:121-6.

140. Williams S. Surrogate endpoints in early prostate cancer research. Translational Andrology and Urology 2018;7:472-82.

141. Williams T, Ngo LH, Wickramasinghe VO. Nuclear export of RNA: Different sizes, shapes and functions. Seminars in Cell and Developmental Biology 2018;75:70-7.

142. Willowson KPR, H.; Jackson, P.; Singh, A.; Eslick, E.; Bailey, D. L. A Comparison of 2D and 3D Kidney Absorbed Dose Measures in Patients Receiving (177)Lu-DOTATATE. Asia Oceania Journal of Nuclear Medicine & Biology 2018;6:113-9.

143. Wong DJY, Donaldson C, Lai LT, Coleman A, Giddings C, Slater LA, Chandra RV. Safety and effectiveness of endovascular embolization or stent-graft reconstruction for treatment of acute carotid blowout syndrome in patients with head and neck cancer: Case series and systematic review of observational studies. Head and Neck 2018;40:846-54.

144. Yeo BR, A. D.; Mouchemore, K. A.; Hamilton, J. A.; Anderson, R. L. The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression. Clinical and Experimental Metastasis 2018;35:255-67.

145. Zhu HB, S.; Chan, K. T.; Pearson, R. B.; Kang, J. Cystathionine beta-Synthase in Physiology and Cancer. BioMed Research International 2018;2018:3205125.